432 related articles for article (PubMed ID: 15313944)
1. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
4. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
5. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
6. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
7. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
[TBL] [Abstract][Full Text] [Related]
8. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
[TBL] [Abstract][Full Text] [Related]
9. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
Maczewski M; Mackiewicz U
Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cardiac events caused by surgical stress in aged rats: simultaneously activating β2-adrenoceptor and inhibiting β1-adrenoceptor.
Sun Y; Wang Y; Zhang L; Xu C; Liu Y; Kang S; Yan C; Li D; Sun H
Stress; 2014 Jul; 17(4):373-81. PubMed ID: 24754893
[TBL] [Abstract][Full Text] [Related]
11. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
[TBL] [Abstract][Full Text] [Related]
12. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
13. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
[TBL] [Abstract][Full Text] [Related]
14. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
[TBL] [Abstract][Full Text] [Related]
15. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
[TBL] [Abstract][Full Text] [Related]
16. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
17. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
19. Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.
Omerovic E; Bollano E; Mobini R; Madhu B; Kujacic V; Soussi B; Hjalmarson A; Waagstein F
Biochem Biophys Res Commun; 2001 Feb; 281(2):491-8. PubMed ID: 11181074
[TBL] [Abstract][Full Text] [Related]
20. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
